drugset / Trial / NCT00170768
Cognitive Effects of Darifenacin and Oxybutynin Extended Release in Volunteers Aged 60 and Over
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to explore the possible cognitive effects of darifenacin modified release and long-acting oxybutynin.
Timeline
- Start
- 2005-02
- Primary completion
- —
- Completion
- 2005-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Darifenacin | Small molecule | 15 mg | — |
| Comparator | Oxybutynin | Small molecule | 20 mg | — |
Indications
No indication recorded.